QMS Medical

Q4 FY25 Earnings Call Analysis

Healthcare Equipment & Supplies

Full Stock Analysis
capex: Yesrevenue: Category 2margin: Category 3orderbook: No informationfundraise: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- The company is currently undertaking a preferential allotment (equity fundraising) to acquire a patient service programs company. - Due diligence and discussions regarding this acquisition are ongoing, with the announcement expected soon, possibly within the current quarter. - The funds raised through the preferential allotment will be used primarily for this acquisition. - For expanding the QDevices brand, capital is expected to come from existing revenue streams, not requiring additional capital raise. - There is no explicit mention of new debt fundraising in the provided excerpts. - The company focuses on growing both patient service programs and product business organically along with acquisitions funded through equity.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- The company has invested approximately INR 15 to 20 crores as capex, primarily towards equipment for Patient Service Camps. Each representative carries machinery worth INR 15 to 17 lakhs. - A significant capex has been brought in for the cancer model as part of new product efforts. - The focus is on increasing the number of technicians and field staff with devices over the next six to eight months to meet high demand. - Capital expenditures also support expansion in patient service programs and product business growth. - The company is pursuing acquisitions in the patient services business; due diligence is ongoing with announcements expected in the current quarter. - Strategic import of products under their own registration from CDSO has begun, to improve margins and reduce dependency on local vendors. - Efforts include expansion of the QDevices brand, increasing online presence, and adding wellness and fitness products.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- The company aims to grow its patient service programs to INR 100 crores over the next three years, up from current INR 15-20 crores annually. - Growth includes acquisition of a similar-sized company expected to double the patient services segment. - Product business is targeted to grow at a steady rate of approximately 15% annually. - Focus on expanding the number of field technicians and dietitians to meet growing demand in patient services. - Online sales to increase gradually by expanding product portfolio beyond current limited range, focusing on wellness and fitness sectors. - The company plans to scale monthly revenues of own brands and patient services, aiming to double current monthly revenues in about a year. - Emphasis on sustainable EBITDA margins through higher-margin patient service camps and direct import of products. - Overall, the company is bullish on patient service programs and QDevices brand growth over the next 2-3 years.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- The company focuses on achieving steady growth over the next 2-3 years rather than projecting long-term 5-year targets due to dynamic business conditions. - Patient service programs are expected to triple in size post-acquisition within the next three years. - Product business aims for a standard growth rate of approximately 15% annually. - EBITDA margins are expected to stabilize and improve from next year onwards as operational expenditures settle. - The company is optimistic about scaling patient service programs significantly, viewing them as a key future growth driver. - EPS showed a 37.9% growth over 9-month FY24 compared to the previous year, reflecting positive financial management and strategic initiatives. - No specific 5-year revenue or profit targets were outlined; focus remains on 2-3 year projections with ongoing revisions based on market conditions.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Current corporates provide enough scope for orders within pharma divisions, with around 30 divisions per company acting like separate companies. - There is significant demand in the existing market plus new opportunities in insurance and other sectors. - The existing order flow is sufficient to keep operations running full-scale. - The company is increasing field technicians and dietitians to meet growing demand, conducting about 100 camps daily across 78 cities. - An acquisition is underway expected to bring in additional order volume, roughly doubling patient services revenue from INR15-20 crores to INR100 crores in three years. - The business model receives bookings via an app from corporate clients which schedule camps at various doctor clinics. - Overall, order inflow and orderbook look healthy with a mix of existing corporate expansions and new business segments.